These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16503850)

  • 21. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
    Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials Group.
    Chen CI; Kouroukis CT; White D; Voralia M; Stadtmauer E; Stewart AK; Wright JJ; Powers J; Walsh W; Eisenhauer E;
    J Clin Oncol; 2007 Apr; 25(12):1570-5. PubMed ID: 17353550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Idelalisib in a patient with refractory Waldenström's macroglobulinemia complicated by anuric renal failure: a case report.
    D'Aveni-Piney M; Divoux M; Busby-Venner H; Muller M; Broséus J; Feugier P
    J Med Case Rep; 2018 Jun; 12(1):164. PubMed ID: 29890999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
    Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
    Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of acute monocytic leukemia in a case of untreated Waldenström's macroglobulinemia.
    Murashige N; Tabanda R; Zalusky R
    Am J Hematol; 2002 Oct; 71(2):94-7. PubMed ID: 12353307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Kidney involvement in Waldenström's disease - case report].
    Fomasi L; Foini P; Marchi G; Ghiringhelli P; Molteni A; Ungari M; Fisogni S; Malberti F
    G Ital Nefrol; 2021 Feb; 38(1):. PubMed ID: 33599424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
    Ise M; Sakai C; Kumagai K
    Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging drugs for Waldenström's macroglobulinemia.
    Kastritis E; Terpos E; Dimopoulos MA
    Expert Opin Emerg Drugs; 2011 Mar; 16(1):45-57. PubMed ID: 21352069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ophthalmic tumor formation in Waldenström's macroglobulinemia.
    Terasaki H; Kikuchi S; Hoshi S
    Jpn J Ophthalmol; 1996; 40(3):385-9. PubMed ID: 8988429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
    Dimopoulos MA; Gertz MA; Kastritis E; Garcia-Sanz R; Kimby EK; Leblond V; Fermand JP; Merlini G; Morel P; Morra E; Ocio EM; Owen R; Ghobrial IM; Seymour J; Kyle RA; Treon SP
    J Clin Oncol; 2009 Jan; 27(1):120-6. PubMed ID: 19047284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral, persistent serous macular detachments with Waldenström's macroglobulinemia.
    Pilon AF; Rhee PS; Messner LV
    Optom Vis Sci; 2005 Jul; 82(7):573-8. PubMed ID: 16044069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral central retinal vein occlusion in Waldenström's macroglobulinemia.
    Avashia JH; Fath DF
    J Am Optom Assoc; 1989 Sep; 60(9):657-8. PubMed ID: 2507620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Waldenstrom's macroglobulinemia.
    Singhal N; Bapsy PP; Babu KG; Sahoo TP
    J Assoc Physicians India; 2004 Dec; 52():981-5. PubMed ID: 15884458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Waldenstrom's macroglobulinemia with antibasement membrane activity of monoclonal immunoglobulin].
    Pech JH; Moreau-Cabarrot A; Oksman F; Bedane C; Bernard P; Bazex J
    Ann Dermatol Venereol; 1997; 124(4):325-8. PubMed ID: 9739939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel agents in the treatment of Waldenström's macroglobulinemia.
    Treon SP; Hatjiharissi E; Leleu X; Moreau AS; Roccaro A; Hunter ZR; Soumerai JD; Ciccarelli B; Xu L; Sacco A; Ngo HT; Jia X; Yang C; Adamia S; Branagan AR; Ho AW; Santos DD; Tournilhac O; Manning RJ; Leduc R; O'Connor K; Nelson M; Patterson CJ; Ghobrial I
    Clin Lymphoma Myeloma; 2007 Aug; 7 Suppl 5():S199-206. PubMed ID: 17877845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current treatment options for Waldenström macroglobulinemia.
    Vijay A; Gertz MA
    Clin Lymphoma Myeloma; 2008 Aug; 8(4):219-29. PubMed ID: 18765309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem cell transplantation (SCT) for Waldenstrom's macroglobulinemia (WM).
    Anagnostopoulos A; Giralt S
    Bone Marrow Transplant; 2002 Jun; 29(12):943-7. PubMed ID: 12098060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.